Please login to the form below

Not currently logged in
Email:
Password:

presbyopia

This page shows the latest presbyopia news and features for those working in and with pharma, biotech and healthcare.

Novartis buys two firms in pre-Christmas shopping spree

Novartis buys two firms in pre-Christmas shopping spree

The takeover of Encore gives Novartis rights to EV06 (lipoic acid choline ester), a disease-modifying treatment for age-related loss of near distance vision (presbyopia) that can be delivered in ... Presbyopia affects 80% of people aged over 45 and makes

Latest news

  • FDA approves wireless contact lens sensor FDA approves wireless contact lens sensor

    In eye care Novartis has licensed the rights to Google's smart lens technology and is developing it for use in diabetes and presbyopia, with clinical trials due to begin later

  • You're in good hands You're in good hands

    Are we throwing expensive presbyopia-correcting intraocular lenses for cataract patients into this basket of goods?

  • Novartis buys rights to Google's 'smart lens' technology Novartis buys rights to Google's 'smart lens' technology

    Novartis buys rights to Google's 'smart lens' technology. Pharma company's eye unit Alcon will focus on uses in diabetes and presbyopia. ... The other is to help people with presbyopia – age-related long-sightedness that makes it more difficult to

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics